COMMUNIQUÉS West-GlobeNewswire

Chembio Diagnostics Announces Major New Tender Win and Certain Preliminary 2017 Financial Results
08/02/2018
MEDFORD, N.Y., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI ) (“Chembio”), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it has won a three-year [...]
BioStem Technologies Adds Chief Revenue Officer to Executive Team
08/02/2018
Pompano Beach, FL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- (GLOBE NEWSWIRE) – BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies [...]
Aduro Biotech to Present at the Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
BERKELEY, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the Leerink [...]
AzurRx BioPharma to Present at the 2018 BIO CEO & Investor Conference (February 12th)
08/02/2018
BROOKLYN, N.Y., Feb. 08, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
CRISPR Therapeutics Announces Transition of Bill Lundberg, MD
08/02/2018
ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP ), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, [...]
The Ensign Group Reports Fourth Quarter and Fiscal Year 2017 Results
08/02/2018
MISSION VIEJO, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, hospice [...]
The Cooper Companies Announces Release Date for First Quarter 2018
08/02/2018
PLEASANTON, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced it will release first quarter 2018 financial results on Thursday, March 8, 2018, at 4:15 PM ET. Following the [...]
Immunomedics Announces Second Quarter Fiscal 2018 Results and Provides Corporate Update
08/02/2018
Presented Compelling Results with Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer (mTNBC) at San Antonio Breast Cancer Symposium Secured $250 Million Funding to Support Company’s Next Growth Phase [...]
Ascendis Pharma A/S Announces Participation in Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
COPENHAGEN, Denmark, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare [...]
Five Prime Therapeutics to Present at LEERINK Partners 7th Annual Global Healthcare Conference
08/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc . (Nasdaq: FPRX ), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today [...]
Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress
08/02/2018
Fluidigm Posts Sequential and Year-Over-Year Quarterly Revenue Growth 2017 Highlights Include Launch of Hyperion Imaging System, Licensing and Distribution Partnerships, Improved Balance Sheet, Double-Digit Operating [...]
ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017
08/02/2018
PORTLAND, Maine, Feb. 08, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC ) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Organovo Announces Fiscal Third-Quarter 2018 Results; Company Updates Full-Year Fiscal 2018 Outlook
08/02/2018
SAN DIEGO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today reported financial results for the fiscal third quarter of 2018 and updated its full-year fiscal 2018 outlook. The [...]
Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights
08/02/2018
MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]
Relievant Announces Publication of Positive Outcomes in 12-Month SMART Sham RCT
08/02/2018
SUNNYVALE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company that developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the [...]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/02/2018
MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Editas Medicine to Participate in Upcoming Investor Conferences
08/02/2018
CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced that it will participate in two upcoming investor conferences. Details are as [...]
Zafgen to Present at the Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
BOSTON, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq: ZFGN ), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
Doctor brings exercise as medicine trend to Toronto
08/02/2018
TORONTO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- A Toronto doctor and his partner have launched Toronto’s first medical fitness clinic catering to boomers suffering from the chronic diseases that come with aging and a [...]

Pages